Sort
15,842 grants matching “pancreatic cancer”
Common Genetically Altered Pathways as Targets for Therapy in Pancreatic Cancer
$392,993Agnieszka Witkiewicz · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Common Genetically Altered Pathways as Targets for Therapy in Pancreatic Cancer
$392,993Agnieszka Witkiewicz · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA
Computational pathology software for integrative cancer research with three-dimensional digital slides
$392,987Jun Kong · Georgia State University · U01 · FY2019 · CA
Target Validation using Gene Knockouts in Somatic Cells
$392,947Robert E Finney · Xactagen, Llc. · R44 · FY2006 · CA
Theranostic nanoparticles for detection and treatment of pancreatic cancer
$392,891Lacey R McNally · Wake Forest University Health Sciences · R01 · FY2016 · EB
Histopathologic validation of 89Zr-DFO-HuMab-5B1 PET/CT imaging in CA 19-9 positive pancreatic cancer
$392,764Neeta Pandit Taskar · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
The Role of post-translational activation of Myc in pancreatic cancer
$392,748Rosalie C Sears · Oregon Health & Science University · R01 · FY2016 · CA
The Role of post-translational activation of Myc in pancreatic cancer
$392,748Rosalie C Sears · Oregon Health & Science University · R01 · FY2015 · CA
Personalization of graphical models using multi-omics data for subtype discovery and prognosis
$392,740Tin C Nguyen · Auburn University At Auburn · U01 · FY2023 · CA
Immune Activating CAR-Modified Antigen Presenting Cells
$392,709Carl Deselm · Washington University · DP5 · FY2019 · OD
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
$392,629Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$392,596Shubham Pant · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
Project 2: Clinical Development of the Pancreatic Cancer Drug Conjugate SW v-49
$392,579William G Hawkins · Washington University · P50 · FY2016 · CA
Mechanisms of homologous recombination in yeast
$392,558Lorraine S Symington · Columbia University Health Sciences · R01 · FY2014 · GM
Developing MRI-Guided Preventive Dendritic Cell Vaccination Strategy to Avoid Post-surgical Pancreatic Cancer Recurrence and Metastasis
$392,500Zhuoli Zhang · University Of California-Irvine · R01 · FY2025 · CA
Developing MRI-Guided Preventive Dendritic Cell Vaccination Strategy to Avoid Post-surgical Pancreatic Cancer Recurrence and Metastasis
$392,500Zhuoli Zhang · University Of California-Irvine · R01 · FY2023 · CA
Exploiting tumor stroma interactions for cancer therapy
$392,486Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · CA
Camptothecin Analogs for Cancer Therapy
$392,344Lee Roy Morgan · Dekk-Tec, Inc. · R44 · FY2011 · CA
Biased chemokine receptor signaling in cancer progression
$392,318Michael B Dwinell · Medical College Of Wisconsin · R01 · FY2021 · CA
Role of extracellular matrix proteins and tumor stroma in DNA repair and cancer progression
$392,306Taru Eliisa Muranen · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
Role of extracellular matrix proteins and tumor stroma in DNA repair and cancer progression
$392,306Taru Eliisa Muranen · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer
$392,242Scott Andrew Gerber · University Of Rochester · R01 · FY2023 · CA
AKT2 Function and Oncogenic Activity
$392,240Joseph Robert Testa · Fox Chase Cancer Center · R01 · FY2006 · CA
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer
$392,238Scott Andrew Gerber · University Of Rochester · R01 · FY2022 · CA
Stromal metabolism promotes therapeutic resistance in pancreatic cancer
$392,124Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R01 · FY2023 · CA